nohealthproblemsnews.com
Home »
Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to a […] Children are just as likely to contract Covid as adults are – but only 50% of kids show symptoms compared […] AstraZeneca’s antibody cocktail can both prevent AND treat Covid, trial data shows New treatment cut risk of serious Covid infection […] One Alaska Native village knew what to do to keep out COVID-19. They put up a gate on the only […] Rural regions in the U.S. have been disproportionately affected by the opioid epidemic, while also having the fewest number of […] Japanese officials sounded the alarm Thursday after Tokyo reported record-breaking coronavirus cases for two straight days with the Olympics well […] Drinking coffee that is caffeinated (ground or instant) or decaffeinated is associated with a reduced risk of developing chronic liver […] Brazil on Saturday became the second country after the United States to surpass 500,000 COVID-19 deaths as the South American […] Australia recommended that AstraZeneca’s COVID-19 jab should not be given to people under 60 on Thursday, a fresh blow to […] New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a […]
Fibroblasts could serve as new key to enhancing personalized treatment for lung cancer patients
Children just as likely to get Covid, only 50% of kids show symptoms
Covid hope as antibody injection both prevents AND treats infection
Rural Alaska at risk as COVID surge swamps faraway hospitals
Mobile telemedicine unit as effective as traditional clinics for treating opioid addiction in rural areas
Officials in Tokyo alarmed as cases hit record highs
Drinking any type of coffee associated with reduced risk of chronic liver disease
Third pandemic wave hits as Brazil surpasses half million COVID deaths
Australia further restricts AstraZeneca vaccine over clotting concerns
Protein identified as new therapeutic anti-viral target for COVID-19
